Is choice a hedge against risk? Maybe.. It's a simple observation. Across multiple industries right now, something fundamental is happening: the illusion of choice is disappearing. Consumers are starting to realize they’re not really choosing. They’re being routed. And when that realization hits they don’t just get frustrated. They push back. We’ve seen it in entertainment, in tech, and now very clearly in healthcare. So here’s the idea I want to leave you with today: Choice

It has been hard to ignore the executive resignations, AI disruptions, and even criminal implications plaguing leadership over the past year. From alleged inappropriate relationships to outright criminal behavior, it raises a difficult question: when screening executives, is the lens too narrowly focused to properly gauge judgment and integrity?

We are entering the end of exceptionalism—an era in which wealth, innovation, and leadership are no longer treated as special cases exempt from scrutiny, taxation, or market discipline. Scale still commands rewards, but it now comes with visibility, accountability, and cost. Is innovation no longer exceptional? Maybe when we consider that for years, Chinese biotech benefited from a kind of innovation exceptionalism where domestic policy protection, licensing instead of full g